Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-11-14
2006-11-14
Low, Christopher S. F. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S482000, C514S611000, C424S422000
Reexamination Certificate
active
07135498
ABSTRACT:
There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.
REFERENCES:
patent: 4439196 (1984-03-01), Higuchi
patent: 4447224 (1984-05-01), DeCant, Jr. et al.
patent: 4447233 (1984-05-01), Mayfield
patent: 4475196 (1984-10-01), La Zor
patent: 4486194 (1984-12-01), Ferrara
patent: 4487603 (1984-12-01), Harris
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-01-01), Frossard
patent: 4925678 (1990-05-01), Ranney
patent: 4959217 (1990-09-01), Sanders et al.
patent: 5167616 (1992-12-01), Haak et al.
patent: 5169383 (1992-12-01), Gyory et al.
patent: 5192659 (1993-03-01), Simons
patent: 5225182 (1993-07-01), Sharma
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5385940 (1995-01-01), Moskowitz
patent: 6284763 (2001-09-01), Adams et al.
patent: WO 95 12394 (1995-05-01), None
patent: WO 99 37616 (1999-07-01), None
patent: WO 00/76318 (2000-12-01), None
Bredt and Snyder, Annual Review of Biochemistry, vol. 63:175-195 (1994).
Poluha, Wojciech et al., Journal of Biological Science vol. 272:38 24002-24007 (1997).
Schipp R. and Gebauer M. invert Neurosci vol. 4:9-15 (1999).
Shaun Hindley, Bernard H. J. Juurlink, John W. Gysbers Pamela J. Maddlemis, Mary A. R. Herman and Micheal P. Rathbone. Journal of Neuroscience Research vol. 47:r427-439 (1997).
Vance G. Nielsen, Manuel S. Baird, Lan Chen, and Sadis Matalon Am. J. of Crit. Care Med. vol. 1611154-1160 (2000).
Ausubel et al.,Current Protocols in Molecular Biology, John Wiley and Sons, Baltimore, Maryland (1989).
Burke and Olson, Methods in Enzymology, vol. 194, “Preparation of Clone Libraries in Yeast Artificial-Chromosome Vectors”, eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 17, pp. 251-270, 1991.
Capecchi, MR. “Altering the genome by homologous recombination”, Science 244:1288-1292, 1989.
Davies, NP., Rosewell, IR., Brüggemann, M. “Targeted alterations in yeast artificial chromosomes for interspecies gene transfer”, Nucleic Acids Research, vol. 20, No. 11, pp. 2693-2698, 1992.
Dickinson, P., Kimber, WL., Kilanowski, FM., Stevenson, B.J., Porteous, DJ., Dorin, JR. “High frequency gene targeting using insertional vector”, Human Molecular Genetics, vol. 2, No. 8, pp. 1299-1302, 1993.
Duff and Lincoln. “Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human APP gene and expression in ES cells”, Research Advances in Alzheimer's Disease and Related Disorders, 1995.
Huxley, C., Hagino, Y., Schlessinger, D., Olson, MV. “The human HPRT gene on a yeast artificial chromosome is functional when transferred to mouse cells by cell fusion”, Genomics, 9:742-750 1991.
Innis MA, Gelfan DH, Sninsky, JJ, White TJ (eds.) “PCR Protocols: A Guide to Methods and Applications,” Academic Press, San Diego, CA 1990.
Jakobovis, A., Moore, AL., Green, LL., Vergara, GJ., Maynard-Currie, CE., Austin, HA., Klapholz, S. “Germ-line transmission and expression of a human-derived yeast artificial chromosome”, Nature, vol. 362, pp. 255-261, 1993.
Johnson, S., Bird, RE. “Construction of single-chain Fvb derivations of monoclonal antibodies and their production ofEscherichia coli”, Methods in Enzymology (JJ Langone, ed.; Academic Press New York, NY) 203:88-99, 1991.
Lamb et al. “Introduction and expression of the 400 kilobaseprecursor amyloid proteingene in transgenic mice”, Nature Genetics, vol. 5, pp. 22-29, 1993.
Mernaugh and Mernaugh. “An overview of phage-displayed recombinant antibodies”, Molecular Methods in Plant Pathology (RP Singh and US Singh, eds.; CRC Press Inc., Boca Raton, FL) pp. 359-365, 1995.
Mishell, BB., Shiigi, SM. Selected Methods in Cellular Immunology, W.H. Freeman and Company, New York, 1981.
Sambrook et al.,Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York (1989).
Testoni N. Martinelli G, Farabegoli P. Zaccaria A, Amabile M, Raspadori D, Pelliconi S, Zuffa E, Carboni C, Tura S. “A New Method of “In-Cell Reverse Transcriptase-Polymerase Chain Reaction” for the Detection of BCR/ABL Transcript in Chronic Myeloid Leukemia Patients,” Blood, vol. 87, No. 9, 3822-3827, May 1, 1996.
Van Wagenen Stefanie, et al., Regulation of neuronal growth cone filopodia by nitric oxide, Journal of Neurobiology, vol. 39, No. 2, May 1999, pp. 168-185.
Chopp Michael
Zhang Rui Lan
Gembeh Shirley V.
Henry Ford Health System
Kohn Kenneth I.
Kohn & Associates PLLC
Low Christopher S. F.
LandOfFree
Nitric oxide donors for inducing neurogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide donors for inducing neurogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide donors for inducing neurogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3655396